Phase II study of arsenic trioxide and temozolomide ut combination with radiation therapy in patients with malignant gliomas Conference

Kumthekar, Priya, Grimm, Sean Aaron, Marymont, MaryAnne H et al. (2014). Phase II study of arsenic trioxide and temozolomide ut combination with radiation therapy in patients with malignant gliomas . JOURNAL OF CLINICAL ONCOLOGY, 32(15), 10.1200/jco.2014.32.15_suppl.2072

cited authors

  • Kumthekar, Priya; Grimm, Sean Aaron; Marymont, MaryAnne H; Mehta, Minesh P; Chandler, James; Muro, Kenji; Jovanovic, Borko; Helenowski, Irene B; McCarthy, Katie; Raizer, Jeffrey J

sustainable development goals

authors

date/time interval

  • May 30, 2014 -

publication date

  • May 20, 2014

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • Chicago, IL

Digital Object Identifier (DOI)

Conference

  • 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

volume

  • 32

issue

  • 15